Do you want to read an article? Please log in or register.
Rising Incidence of Neuroendocrine Neoplasms in Northern Switzerland-Data From the Cancer Registry
Endocrine and Neuroendocrine Tumors (NET)
Related content
RECOMMENDED
Gastrointestinal Cancer
Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Eur J Cancer
Fournier E, Schaffar R, Staehelin K, Rouxel N, Ris F, Toso C, Frossard JL, Rapiti E, Koessler T, Wildisen L, Meyer J
doi: 10.1016/j.ejca.2026.116707
COVID-19
Impact of the COVID-19 pandemic and its measures on one-year and three-year cancer survival using Swiss cantonal cancer registry data
Cancer Causes Control
Suter F, Wanner M, Wicki A, Korol D, Rohrmann S
doi: 10.1007/s10552-026-02175-8
Gastrointestinal Cancer
Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study)
Int J Cancer
Goetze TO, Al-Batran SE, Liersch R, Scheuer L, Goehler T, Kaiser U, Denzlinger C, Brandl S, Pink D, Uhlig J, Maasberg M, Loose M, Schaaf M, Sookthai D, Zäpf B, Pauligk C, Habibzade T, Hofheinz RD, Koch C, AIO Study Group
doi: 10.1002/ijc.70280
Genitourinary Cancer
Prostate Cancer Incidence, Mortality, and Survival in Switzerland
JAMA Netw Open
Menges D, Wildisen L, Scherer T, Tancredi S, Würnschimmel C, Sigg S, Hao S, Lippuner M, Cathomas R, Templeton AJ, Chmiel C, Rentsch CA, Eberli D, Kwiatkowski M, Mortezavi A, Chiolero A, Rohrmann S, Clements M, Staehelin K
doi: 10.1001/jamanetworkopen.2026.8289
Gastrointestinal Cancer
Trends in Pancreatic Cancer Incidence, Mortality and Net Survival: A Population-Based Analysis in Zurich (Switzerland), 1981-2021
J Gastrointest Cancer
Vinci L, Wanner M, Wicki A, Moch H, Korol D, Rohrmann S
doi: 10.1007/s12029-026-01498-8
Breast Cancer
Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registry
Int J Cancer
Marschner P, Ringwald K, Thill M, Zahn MO, Welt A, Nusch A, Kaltenecker G, Rodemer Y, Hagen V, Schock C, Kruggel L, Kaiser-Osterhues A, Klein D, Haug N, Stickeler E, Harbeck N, Wöckel A, Marschner N, Decker T, OPAL Registry Group
doi: 10.1002/ijc.70433
Lung, Respiratory and Thoracic Cancer
Paraneoplastic Lambert-Eaton myasthenic syndrome associated with non-small cell lung cancer: data from the European LEMS registry and systematic review
Neurol Res Pract
Preßler H, Haddy I, Daugherty C, Postila V, Meisel A
doi: 10.1186/s42466-025-00453-5
Further Publications
Incidence patterns and temporal trends of childhood cancer in Germany, 1980-2019: Forty years of childhood cancer registration in Germany
Int J Cancer
Erdmann F, Wellbrock M, Trübenbach C, Grabow D, Schrappe M, Kaatsch P, Spix C, Schüz J, Ronckers CM
doi: 10.1002/ijc.70167
Head and Neck Cancer
Trends and efficacy of definitive radiotherapy regimens for locally advanced head and neck cancer in elderly patients: A population-based analysis by the German cancer registry group
Eur J Cancer
Tinhofer I, Hofmann E, Trelinska-Finger A, Saraei T, Keilholz U, Heiland M, Letsch A, Knödler M, Beck M, Klinghammer K, Dommerich S, Wittenberg I, Reinwald F, Sackmann A, Klinkhammer-Schalke M, Zeissig SR, Weitmann K, Franke B, Schneider C, Zips D, Doll C
doi: 10.1016/j.ejca.2025.116039